Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Phase I Study to Evaluate Bioavailability of Overencapsulated Celecoxib

This study has been completed.
Sponsor:
Collaborator:
AstraZeneca
Information provided by:
POZEN
ClinicalTrials.gov Identifier:
NCT00729495
First received: August 5, 2008
Last updated: May 12, 2009
Last verified: May 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2008
  Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)